Harrison.ai has petitioned the FDA to exempt some radiology AI devices from premarket review, prompting mixed feedback from industry stakeholders.
Key Details
- 1Harrison.ai seeks FDA exemption for certain computer-aided detection (CAD) AI devices from premarket review.
- 2The company argues current US regulatory pathways are too burdensome for rapidly evolving AI.
- 3Stakeholder comments included feedback from RSNA, ACR, and Patient Alliance for Safe Imaging.
- 4ACR emphasized the need to prioritize patient safety and warned against unintended safety risks.
- 5Harrison.ai has 8 FDA clearances covering 12 indications and its products serve over 1,000 facilities in 40 countries.
- 6Consulting firm Rubrum Advising submitted the petition in October 2023.
Why It Matters
If granted, this exemption could significantly alter the regulatory landscape for radiology AI software, balancing innovation access against patient safety concerns. The decision will set a precedent for future AI device oversight in imaging.
Source
Radiology Business
Related News
•AuntMinnie
ECR 2026: Radiologists Push for Stronger Evidence and EU Support in Imaging AI
European radiologists at ECR 2026 call for more resources to achieve strong evidence and societal impact for radiology AI, especially under new EU HTA regulation.
•HealthExec
AI's Expanding Role in Healthcare: Clinician and Patient Perspectives
Healthcare workers, especially nurses and doctors, are grappling with the real-world impacts of AI integration, while patients are encouraged to use AI thoughtfully in medical interactions.
•Radiology Business
Radiology Demonstrates How AI Boosts, Not Replaces, Human Jobs
Despite over 1,000 FDA-cleared AI radiology tools, human radiologists remain essential, with job growth projected to continue.